Abstract An accurate estimate of the impact of toxoplasmosis on the population in Italy is not available. We performed a cross-sectional study on individuals living in Italy to assess: (1) differences in access to Toxo testing and in the prevalence of recent and past Toxoplasma gondii infection according to gender and age, and (2) the clinical impact of disease burden on the male patient subset. Reason for testing, condition of in-or outpatient and clinical data were analysed. Between-gender differences were observed in access to the test. Immunoglobulin M (IgM) prevalence was increased in males in the age range 5-34 years [odds ratio (OR) = 2.03, 95% confidence interval (CI) 1.18-3.49, p = 0.01), with a peak at 25-34 years. In females, it decreased in the age range 20-39 years (OR = 0.49, 95% CI 0.32-0.74, p = 0.0008). The attack rate of recent infection was twice as high for males than for females. Estimates pointed out 3.3 and 1.7 events in 1000 at-risk person-years in the male and female cohorts, respectively. Most IgM-positive subjects did not experience severe forms of toxoplasmosis, with 35% having lymphadenopathy. Chorioretinitis, systemic and neurological manifestations were also observed. Our findings suggest that the acute phase of toxoplasmosis is largely unapparent or clinically mild in this area. It is also possible that the disease burden for Toxoplasma infection in Italy is underestimated. Further study should focus on information acquisition and Toxo test access in hospital units for a better estimation of the real burden of mild and severe forms of the disease.
Introduction
Over 2 billion people have been estimated to be infected worldwide with the coccidian protozoan Toxoplasma gondii (Tg). A primary infection is usually followed by short-term persistence of Toxoplasma-specific immunoglobulin M (IgM) antibodies and life-long persistence of Toxoplasma-specific immunoglobulin G (IgG) antibodies. Tg IgG prevalence is considered a measure of the lifetime accumulated exposure, thus increasing with age [1, 2] .
In most of the immunocompetent people living in the USA and the EU, Tg infection (TgI) occurs subclinically or as a minor self-limiting illness not requiring treatment (including fever, lymph node enlargement, arthralgia/myalgia, mononucleosis-like illness and macular rash) [3] . The risk of severe infection with systemic, central nervous system (CNS) and ocular involvement is higher in specific patient groups, including congenitally infected foetuses and newborns, immunologically impaired individuals, such as human immunodeficiency virus (HIV)-infected, solid organ or hematopoietic stem cell transplanted or cancer patients, and people on immunosuppressive treatment [4] [5] [6] [7] [8] [9] . Conditions requiring hospitalisation include pneumonitis, myocarditis, hepatitis and posterior pole uveitis, with potential visual loss. Reactivation of the disease can present as retinochorioiditis (more often recorded at the borders of chorioretinal scars) [10] , pneumonitis or multi-organ involvement, including acute respiratory failure and haemodynamic abnormalities similar to septic shock [3] . Recently, the association of chronic TgI with traffic accident risk and neuropsychiatric and moods disorders, including schizophrenia and other neurodegenerative diseases, has been pointed out, thus opening a new field of research [8, [11] [12] [13] [14] . The seroprevalence of TgI shows wide variability among countries, and even within a given country, ranging from 10% to 80%. Prevalence is lower in North America and Asia compared to South America and Africa, with Europe lying in between [15] . Geoclimate, the environment parasite load, presence of highly virulent strains, anthropogenic factors, including personal hygiene, cultural and food habits, socioeconomic status, educational level, residence in rural or urban area, occupational exposure and infection rate of the animal reservoirs also play a role [15, 16] . During the last several decades, a decrease in seroprevalence has been shown in medium-and high-income populations, mostly in northern Europe and the USA. It is considered to be a consequence of changes in food safety and hygienic habits, prevention and control measures in food preservation and manipulation, industrial preparation procedures and modern farming methods [1, 17] . The decline was stronger in younger individuals [2, 18] . Furthermore, an effect of primary prevention endorsed on prenatal screening programmes cannot be excluded [1] .
Most of the prevalence surveys have had the child-bearing age female population as a target, whereas only a few studies included the male population. Differences between genders have not been considered significant or have been displayed in specific age ranges [19] [20] [21] . Our previous studies suggested a higher age-related prevalence for Toxoplasma infection in men compared to women in the Tuscany region, in central Italy [18, 22] .
The main objectives of the present cross-sectional survey carried out in this geographical area are to assess differences in access to testing and the prevalence of recent and past TgI according to gender and age. In the male patient subgroup, disease burden was measured based on the reason for the prescription and condition of in-or outpatient.
Materials and methods

Geodemographic characteristics of the study area
The study area is located in the north-west part of Tuscany, central Italy, in two contiguous administrative districts, namely Pisa and Lucca. The geodemographic profile is summarised in Table 1 [23, 24] .
Selection of patients
Starting January 1, 2010 and ending June 30, 2013, sera from a sequential sample of people accessing serological tests for specific Tg IgG and IgM antibodies (Toxo testing) in two public central laboratories of the National Health Service (NHS) were analysed.
Overall, 12,529 subjects entered the study, including 3501 males and 9028 females. After data anonymisation, date and reason for sampling, condition of in-or outpatient and practitioner requesting the test at the laboratory level, were analysed; incomplete records were omitted. Multiple record assignment to the same patient was excluded by selection of the first date of sampling. In sequentially tested people, the occurrence of seroconversion or positive confirmatory test results, including low IgG avidity and/or remarkable increase in the IgG level, was updated in the dataset.
Case definition
The Toxo test was carried out according to the manufacturer's instructions and routine by using Toxo IgG and IgM commercial immunoenzymatic kits on a Cobas E Elecsys analyser (Roche Diagnostics). IgG concentrations ≥3 IU/mL, 1-2.9 IU/mL and <1 IU/mL were the cut-offs for positive, undetermined or no reactive result, respectively. Undetermined samples were re-tested on the same serum sample; twice undetermined results were omitted. Subjects displaying positive IgG and negative IgM were considered past TgI. The IgM cut-off index (CoI) was categorised as reactive, indeterminate and non-reactive according to the value (≥1.0, ≥0.8 to < 1.0 and <0.8, respectively An overall association between seroprevalence and age in male and female subjects, and differences between groups were calculated with the Cochran-MantelHaenszel general association Chi-squared test (CMH chi-squared test for linear trend). Differences between small groups were calculated with Fisher's exact test.
To assess the association between a single dichotomous outcome (IgG or IgM positivity) and more than one independent variable (gender, nationality and condition of in-or outpatient) adjusting for age, a multivariable logistic regression analysis was applied using sampling weights. Statistical significance was declared at a p-value <0.05.
Results
Toxo testing access
The age at test ingress ranged from 1 day to 93 years, mean ± standard deviation (SD) 31.3 ± 19.7 years in the male and 32.9 ± 10.2 years in the female cohorts, respectively. Two hundred and twenty-three subjects (1.8%) were in the age range 0-12 months ( Table 2 ). The age distribution of testing according to local demographics are shown in Fig. 1 . In the male cohort, testing was widespread over the entire age range, although a slight increase was appreciated in the age range 15-24 years. In the female cohort, as expected, a peak in testing was reported in the age range 25-39 years. Differences in age of testing according to gender were significant (Chi square test for trend 10.28, p = 0.0013) after adjusting for the 5-year age group.
Overall, 2201 individuals (17.5%) were foreign-born. Among these, 294 (13.3%) were males and 1907 (86.8%) were females. Foreign-born individuals were a minority in the male cohort (8.4%) and 1 out 5 (21.0%) in the female cohort (Table 2) , being nearly 1.0% and 5.7% of the male and female foreign-born populations, respectively [22] . Countries of origin were mainly Romania (21.1%), Albania (20.3%) and Morocco (11.7%). The age range in the foreignborn subjects was 1 day to 78 years (mean ± SD 23.6 ± 17.3) in the male and 1 day to 81 years (mean ± SD 29.3 ± 7.8) in the female cohorts. In native individuals, the age range was 1 day to 93 years (mean ± SD 32.0 ± 19.8) in males and 1 day to 98 years (mean ± SD 33.8 ± 10.5) in females.
Prevalence of past TgI (IgG)
Children aged 0-12 months have been excluded by the analysis of past infection since their IgG positivity likely reflected a maternal transfer. As a consequence, the analysis was carried out on 12,306 subjects (3301 males and 9005 females Fig. 2a , a positive trend of anti-Toxo IgG positivity according to age was shown in both genders, with the lowest prevalence in the youngest age group (p < 0.0001). IgG prevalence increased with increasing age (Chi-squared for trend = 814, p < 0.0001 for males; Chi-squared for trend = 547, p < 0.0001 for females). Over the age range 25-69 years, the trend slope was higher in the male than in the female cohort (p < 0.0001; OR = 1.59, 95% CI 1.44-1.75). Among children aged 1-4 years, IgG seropositivity was shown to be quite low (<5.0%). IgG prevalence was significantly higher in foreign-born men (p = 0.0027) and women (p < 0.0001) compared to native individuals.
Prevalence of recent TgI (IgM)
Overall, specific IgG and IgM were detected in 164/12,306 subjects (1.3%). Prevalence was significantly higher (Chi-squared = 9.651, p = 0.0019) in males (62/3301 = 1.9%) than in females (101/9005 = 1.1%) (Fig. 2b) .
Among subjects under the age of 12 months, 2 (0.9%) cases with IgG and IgM positivity were reported; they were excluded from the analysis as they were possible cases of congenital TgI. A difference in the attack rate of recent infection was detected in the age range 25-34 years (5.2% vs. 1.4% in the male and female cohorts, respectively; p <0.0001; OR = 3.67, 95% CI 2.20-6.10, p < 0.0001). Estimates were 3.3 events in 1000 atrisk person-years in the male cohort and 1.7 events in 1000 atrisk person-years in the female cohort. IgG and IgM positivity in the female cohort peaked in the age range 45-54 years. a b Fig. 1 Age distribution of testing according to demographics on male (a) and female (b) subjects in the area of study
Clinical impact of recent infection
Overall 1530/12,529 (12%) subjects were in hospital care, including 1321/12,306 (11%) patients aged over 12 months and 209/223 (94%) under 12 months of age. In the <12 months patient subgroup, 25 were IgG and IgM positive (data not shown). Serological tests for Toxoplasma in this group of children were mostly requested by the Division of Newborn Medicine (82.8%) and included mainly (91.8%) male subjects. The adult (over 12 months of age) inpatient cohort included 1030 male (78%) and 291 (22%) female subjects, whereas the outpatient cohort included 2271 (21%) men and 8714 women (79%), respectively.
The distribution of patients over 1 year of age with positive Toxo IgM and IgG antibody results according to the care setting and medical specialty area making the prescription is shown in Table 3 .
In the IgG and IgM positive cohort (164 patients), 24/164 (15%) subjects were inpatients, including 17 (70%) males and 7 (30%) females, respectively, whereas 140/164 (85%) were outpatients, including 45 (32%) males and 95 (68%) females, respectively. Among inpatients, the proportion of males to females was ten-fold higher. The gender-related difference in recent infections on care setting was significant (p = 0.0007) with the OR for conditions of inpatients being five times greater in males than in females (OR = 5.13, 95% CI 1.98-13.24).
Nearly half (573/1321) of the in-hospital diagnostic requests were carried out by the infectious disease specialist, and 12/573 (2.1%) were reported as IgG and IgM positive. Indeed, the prescriptions among males were mainly carried out by infectious disease specialist (488, 47.4%) and reported as IgG and IgM positive in 10 (58.8%) patients. In the female cohort, the requests were mainly carried out by the Obstetrics and Gynaecology Department (52; 17.9%) and reported as positive in 1 (14.3%).
Among all inpatients (men and women), only a small percentage of prescriptions was carried out by the Departments of Ophthalmology and Neuropsychiatry (0.23% and 2.4%, respectively).
In the 62 male patients with positive IgG and IgM results, the indication for the Toxo test request and diagnosis on the hospital discharge card based on the diagnosis-related group (DRG) for inpatients were analysed and the results displayed in Table 4 .
In the large majority of cases, the suspicion was based on lymph node enlargement combined or not with general findings (45, 72.6%), whereas in a minority (4, 6.4%) it was reported the presence of more serious illness, including systemic manifestation and/or ophthalmologic or neurological findings. Thirteen patients (21%) were investigated because they were considered at risk for toxoplasmosis complication due to immunological depression (two of them were HIV-infected). One young adolescent was on follow-up for congenital toxoplasmosis.
In 5 out of these 62 patients (8.0%), the DRG had the code 130.0 to 130.9. The discharge diagnosis was lymphadenopathy (five cases). A DRG including codes 130.0 to 130.9 was reported for some patients who entered the study in whom IgG was positive and IgM was negative (8) . In one of them, the primary diagnosis was toxoplasmic retinochorioiditis; for a further five cases, the primary diagnosis was toxoplasmic encephalitis and two were diagnosed as non-specific toxoplasmosis. None of them were included in Table 3 . Overall, 20/ 1030 (1.9%) Toxo IgG positive male subjects had a diagnosis of toxoplasmosis and 8/20 (40%) were IgM negative.
Discussion
For decades, the focus on toxoplasmosis has been on the prevention and treatment of primary toxoplasmosis during gestation to taper the consequences of in utero acquired infection (pre-screening). As a consequence, area-based studies on the prevalence of chronic and acute TgI were centred on the reproductive age female population [15] and effectiveness of prenatal versus newborn screening, as well as health education campaigns. Only studies focusing on specific target groups for a b Fig. 2 Age-specific prevalence of Toxoplasma gondii immunoglobulin G (IgG, a) and immunoglobulin M (IgM, b) antibodies in the study cohors severe toxoplasmosis included male subjects or persons over 45 years of age [21, [25] [26] [27] . In most studies, no gender-related difference in IgG prevalence was observed [1, 2] . However, in a few nationwide population-based serosurveillance studies carried out in the USA, the IgG prevalence in men was higher than that in women. In the National Health and Nutrition Examination Survey (NHANES) 2009-2010 study, Toxoplasma IgG prevalence was 13.8% for men and 11.1% for women, respectively [28] . In the National Inpatient Sample (NIS), the estimated age-adjusted toxoplasmosis hospitalisation rate in non-HIV patients was significantly higher in the male population than in females (0.0020 vs. 0.0013, respectively) [29] . Recently, the question on possible gender differences arose in France [21] . The authors' conclusion was that there are no differences in the population aged 18-45 years or under. In the same study, there was an upwards trend during adolescence (10-20 years of age).
In Italy, a nationwide surveillance system for TgI is lacking, and surveillance for congenital TgI (CT) has been routinely performed only on a regional basis in Campania, southern Italy [30, 31] . As a consequence, accurate estimate of toxoplasmosis impact on the population in our country is not available and up-to-date epidemiological information about the prevalence of recent and past TgI relies on cross-sectional studies, mostly hospital-or area-based and centred on reproductive age (15-45 years) , and a few in at-risk groups of the population [32] [33] [34] . To our knowledge, the present study is the first snapshot of the burden of TgI in the adult population accessing Toxo testing in a defined geoadministrative area of Italy with regard to gender differences.
The observed between-gender differences in access to testing may be a consequence of a widely practised testing (all over Italy) for the prevention of CT. In fact, prenatal testing is part of the charge-free list of tests to carry out in the pre-and postconceptional periods, including the non-resident pregnant population. Differences in diagnostic requests, i.e. prevention versus clinical scope, were confirmed by the highly significant gender-related differences in the hospitalisation rate. In foreign-born individuals, the proportion of males submitted to Toxo test compared to females (8.4% vs. 21.1%) is even lower than in native individuals, probably as a consequence of difficult access problems for testing. Indeed, these data confirm that, also, immigrant women are the part of the object of health information programmes. The seroprevalence of toxoplasmosis increased with age in both genders, confirming that infection occurs throughout life, with the lowest IgG positivity in the youngest age groups. An upward trend was pointed out during late adolescence (over 15 years of age) in both genders, when dietary habits change and many more meals are consumed outside. In the 25-69 years age range, the seroconversion rate is higher in the male cohort than that in the female cohort, possibly depending on different habits according to occupation, including systematic outdoor meal consumption and employment on a small scale in agriculture, animal breeding and meat slaughtering, and manufacturing. The lower prevalence observed in women can reflect, in fact, a widespread adoption of preventive measures due to a greater awareness of the disease risk associated with primary toxoplasmosis during gestation. Accordingly, the prevalence of recent infection was higher in men than in women. A two-fold attack rate was detected in males compared to females in the age range 25-34 years, which corresponds to the peak of delivery in Italy) [23] .
The IgM peak was observed earlier in males compared to females, confirming that men become infected before women. Indeed, similarly to the trend observed for IgG antibodies, the IgM prevalence in males is higher than that in females up to 40 years of age, whereas in women, the IgM increase is shifted to the over 55 years age group. An age-specific IgM decrease of prevalence in women aged 20-39 years was observed. It is conceivable that the effectiveness of prevention strategies carried out among women of child-bearing age in our country underlies this gender gap. However, it may also be assumed that this difference is affected by differences in access to healthcare or in health behaviour.
Conclusion
This study allowed us to identify the most important gaps in information acquisition to plan and improve intervention programmes and further research. One potential limitation of the current study is that it lacks information on exposure to potential risk factors. In spite of this, most of the subjects with IgM positivity do not present severe forms of toxoplasmosis. It might be argued that the acute phase of acquired toxoplasmosis in this geographical area is largely unapparent or mild. However, it is possible that the disease burden for Toxoplasma infection in Italy is underestimated.
When analysing data of the distribution of inpatients for which a test was requested, it is important to note that possible symptomatic cases did not follow the declining trend of seroprevalence observed during the 4-year period in the whole population examined. As expected, the Departments from which requests were most frequently received were Infectious Diseases, Paediatrics, and Obstetrics and Gynaecology. Further study should focus on Toxo test access in particular hospital units (ophthalmologic, transplantation and intensive care) in order to assess the real burden of mild and severe disease.
